The selenium content of cell culture serum infuences redox-regulated gene expression

BioTechniques

Volumn 50, Issue 5, 2011, Pages 295-301

  Karlenius, Therese C ^a   Shah, Fenil ^a   Yu, Wei Che ^a   Hawkes, Hye Jin Kim ^a   Tinggi, Ujang ^b   Clarke, Frank M ^a   Tonissen, Kathryn F ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b QUEENSLAND HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P53; SELENIUM; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR SP1;

CELL CULTURE; CELL GROWTH; CULTURE MEDIUM; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HOMEOSTASIS; LETTER; MASS SPECTROMETRY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; SERUM; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANTIOXIDANTS; CELL PROLIFERATION; CULTURE MEDIA; GENE EXPRESSION; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HUMANS; OXIDATION-REDUCTION; PROMOTER REGIONS, GENETIC; SELENIUM; SERUM; THIOREDOXIN-DISULFIDE REDUCTASE; TUMOR CELLS, CULTURED;

EID: 79957731140     PISSN: 07366205     EISSN: 19409818     Source Type: Journal    
DOI: 10.2144/000113666     Document Type: Letter

References (34)

1. Cohly, H., J. Stephens, A. Markhov, M. Angel, W. Campbell, K. Ndebele, and J. Jenkins. 2001. Cell culture conditions affect LPS inducibility of the inflammatory mediators in J774A.1 murine macrophages. Immunol. Invest. 30:1-15.
2. Proulx, S., S. Landreville, S.L. Guerin, and C. Salesse. 2004. Integrin alpha5 expression by the ARPE-19 cell line: comparison with primary RPE cultures and effect of growth medium on the alpha5 gene promoter strength. Exp. Eye Res. 79:157-165.
3. Tian, J., K. Ishibashi, S. Honda, S.A. Boylan, L.M. Hjelmeland, and J.T. Handa. 2005. The expression of native and cultured human retinal pigment epithelial cells grown in different culture conditions. Br. J. Ophthalmol. 89:1510-1517.
4. Shahdadfar, A., K. Fronsdal, T. Haug, F.P. Reinholt, and J.E. Brinchmann. 2005. In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells 23:1357-1366.
5. Turnovcova, K., K. Ruzickova, V. Vanecek, E. Sykova, and P. Jendelova. 2009. Properties and growth of human bone marrow mesenchymal stromal cells cultivated in different media. Cytotherapy 11:874-885.
6. Arner, E.S. and A. Holmgren. 2000. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 267:6102-6109.
7. Lillig, C.H. and A. Holmgren. 2007. Thioredoxin and related molecules-from biology to health and disease. Antioxid. Redox Signal. 9:25-47.
8. Turanov, A.A., S. Kehr, S.M. Marino, M.H. Yoo, B.A. Carlson, D.L. Hatfield, and V.N. Gladyshev. 2010. Mammalian thioredoxin reductase 1: roles in redox homoeo-stasis and characterization of cellular targets. Biochem. J. 430:285-293.
9. Arrigo, A.P. 1999. Gene expression and the thiol redox state. Free Radic. Biol. Med. 27:936-944.
10. Bloomfield, K.L., S.A. Osborne, D.D. Kennedy, F.M. Clarke, and K.F. Tonissen. 2003. Thioredoxin-mediated redox control of the transcription factor Sp1 and regulation of the thioredoxin gene promoter. Gene 319:107-116.
11. Ema, M., K. Hi rota, J. Mimura, H. Abe, J. Yodoi, K. Sogawa, L. Poellinger, and Y. Fujii-Kuriyama. 1999. Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300. EMBO J. 18:1905-1914.
12. Hirota, K., M. Matsui, S. Iwata, A. Nishiyama, K. Mori, and J. Yodoi. 1997. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc. Natl. Acad. Sci. USA 94:3633-3638.
13. Matthews, J.R., N. Wakasugi, J.L. Virelizier, J. Yodoi, and R.T. Hay. 1992. Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res. 20:3821-3830.
14. Ueno, M., H. Masutani, R.J. Arai, A. Yamauchi, K. Hirota, T. Sakai, T. Inamoto, Y. Yamaoka, et al. 1999. Thioredoxin-dependent redox regulation of p53-mediated p21 activation. J. Biol. Chem. 274:35809-35815.
15. Arthur, J.R. 2000. The glutathione peroxidases. Cell. Mol. Life Sci. 57:1825-1835.
16. Gladyshev, V.N., K.T. Jeang, and T.C. Stadtman. 1996. Selenocysteine, identified as the penultimate C-terminal residue in human T-cell thioredoxin reductase, corresponds to TGA in the human placental gene. Proc. Natl. Acad. Sci. USA 93:6146-6151. 17.
17. Zhong, L., E.S. Arn-er, J. Ljung, F. Aslund, and A. Holmgren. 1998. Rat and calf thioredoxin reductase are homologous to glutathione reductase with a carboxyl-terminal elongation containing a conserved catalytically active penultimate selenocysteine residue. J. Biol. Chem. 273:8581-8591.
18. Welsh, S.J., W. T. Bellamy, M.M. Briehl, and G. Powis. 2002. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angio-genesis. Cancer Res. 62:5089-5095.
19. Osborne, S.A., H.J. Hawkes, B.L. Baldwin, K.A. Alexander, T. Svingen, F.M. Clarke, and K.F. Tonissen. 2006. The tert-butylhydroquinone-mediated activation of the human thioredoxin gene reveals a novel promoter structure. Biochem. J. 398:269-277.
20. Tonissen, K.F. and J.R. Wells. 1991. Isolation and characterization of human thioredoxin-encoding genes. Gene 102:221-228.
21. Kim, Y.C., H. Masutani, Y. Yamaguchi, K. Itoh, M. Yamamoto, and J. Yodoi. 2001. Hemin-induced activation of the thioredoxin gene by Nrf2. A differential regulation of the antioxidant responsive element by a switch of its binding factors. J. Biol. Chem. 276:18399-18406.
22. Kim, Y.C., Y. Yamaguchi, N. Kondo, H. Masutani, and J. Yodoi. 2003. Thiore-doxin-dependent redox regulation of the antioxidant responsive element (ARE) in electrophile response. Oncogene 22:1860-1865.
23. Tanito, M., H. Masutani, Y.C. Kim, M. Nishikawa, A. Ohira, and J. Yodoi. 2005. Sulforaphane induces thioredoxin through the antioxidant-responsive element and attenuates retinal light damage in mice. Invest. Ophthalmol. Vis. Sci. 46: 979-987.
24. Cailleau, R., R. Young, M. Olive, and W.J. Reeves, Jr. 1974. Breast tumor cell lines from pleural effusions. J. Natl. Cancer Inst. 53:661-674.
25. Steinbrenner, H. and H. Sies. 2009. Protection against reactive oxygen species by selenoproteins. Biochim. Biophys. Acta 1790:1478-1485.
26. Tinggi, U., T. Gianduzzo, R. Francis, D. Nicol, M. Shahin, and P. Scheelings. 2004. Determination of selenium in red blood cells by inductively coupled plasma mass spectrometry (ICP-MS) after microwave digestion. J. Radioanal. Nucl. Chem. 259:469-472.
27. Fujino, G., T. Nog uchi, K. Takeda, and H. Ichijo. 2006. Thioredoxin and protein kinases in redox signaling. Semin. Cancer Biol. 16:427-435.
28. Wang, G.L., B.H. Jiang, E.A. Rue, and G.L. Semenza. 1995. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 ten sion. Proc. Natl. Acad. Sci. USA 92:5510-5514.
29. Zhong, L. and A. Holmgren. 2000. Essential role of selenium in the catalytic activities of mammalian thioredoxin reductase revealed by characterization of recombinant enzymes with selenocysteine mutations. J. Biol. Chem. 275:18121-18128.
30. Smith, A.D. and O.A. Levander. 2002. High-throughput 96-well microplate assays for determining specific activities of glutathione peroxidase and thioredoxin reductase. Methods Enzymol. 347:113-121.
31. Menth, M., C. Schmutzler, B. Mentrup, C. Hoang-Vu, K. Takahashi, T. Honjoh, and J. Kohrle. 2005. Selenoprotein expression in Hurthle cell carcinomas and in the human Hurthle cell carcinoma line XTC.UC1. Thyroid 15:405-416.
32. Zheng, Y., L. Zhong, and X. Shen. 2005. Effect of selenium-supplement on the calcium signaling in human endothelial cells. J. Cell. Physiol. 205:97-106.
33. Manalo, D.J., A. Rowan, T. Lavoie, L. Natarajan, B.D. Kelly, S.Q. Ye, J.G. Garcia, and G.L. Semenza. 2005. Transcrip-tional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 105:659-669.
34. Wakabayashi, N., S.L. Slocu m, J.J. Skoko, S. Shin, and T.W. Kensler. 2010. When NRF2 talks, who's listening? Antioxid. Redox Signal. 13:1649-1663.